About Ganirelix Acetate Injection
Ganirelix Acetate Injection is a gonadotropin-releasing hormone (GnRH) antagonist that is used to suppress premature luteinizing hormone (LH) surges in women during assisted reproductive technology (ART) treatment. This prevents eggs from being released prematurely.
Women who are using an injectable gonadotropin, such as Follistim® AQ Cartridge (follitropin beta injection), may also be prescribed Ganirelix Acetate Injection because an injectable gonadotropin stimulates the growth of multiple follicles, which can cause an early rise in LH.
Like a GnRH agonist, Ganirelix Acetate Injection (an GnRH antagonist) is effective in preventing LH surges. Unlike a GnRH agonist, Ganirelix rapidly acts to prevent the LH surge after its initial injection.
The gonadotropin-releasing hormone (GnRH) antagonist Ganirelix Acetate Injection contains the active ingredient ganirelix acetate.
Ganirelix Acetate Injection is given on average five days mid-cycle gonadotropin stimulation. This translates to several benefits:
- Shorter treatment days.
- Lesser total medication is used.
- Fewer injections are needed.
Ganirelix Acetate Injection is the only GnRH antagonist in a ready-to-use pre-filled syringe, which means it is easy to administer because mixing isn't required. One pre-filled syringe of Ganirelix Acetate Injection contains 250 micrograms of ganirelix acetate. Ganirelix Acetate Injection can be stored at room temperature.